| Pronunciation |
 (DYE
noe prost tro METH a
meen) |
 |
| U.S. Brand Names |
| Prostin F2 Alpha® |
|
| Generic Available |
|
No |
|
| Synonyms |
| PGF2a; Prostaglandin F2 Alpha |
|
| Pharmacological Index |
|
Prostaglandin |
|
| Use |
|
Abort 2nd trimester pregnancy |
|
| Pregnancy Risk Factor |
|
X |
|
| Contraindications |
|
Hypersensitivity to dinoprost tromethamine; acute pelvic inflammatory disease; uterine fibroids; cervical stenosis |
|
| Adverse Reactions |
|
1% to 10%: Miscellaneous: Uterine infection |
|
| Usual Dosage |
|
40 mg (8 mL) via transabdominal tap, if abortion not completed in 24 hours, another 10-40 mg may be given |
|
| Mental Health: Effects on Mental Status |
|
None reported |
|
| Mental Health: Effects on Psychiatric Treatment |
|
None reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Injection: 5 mg/mL (4 mL, 8 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
